Eating disorder specialists have already raised concerns about the potential impact of GLP-1 drugs on people with a history of disordered eating
Track how your clothes fit, how your energy feels throughout the day, how your sleep quality changes, and how your physical capabilities improve
Research into metabolic effects of GLP-1 receptor agonists shows these medications can influence energy expenditure and substrate metabolism
For decades, there has been growing evidence of a relationship between metabolism and malignant cell proliferation
Retatrutide is investigational and not FDA-approved for any use as of 2026
Peptide Vials (Retatrutide, 10 mg each): 12 weeks (Standard to 6 mg): 5 vials 24 weeks (Standard to 8 mg): 15 vials 12 weeks (Aggressive to 8 mg): 6 vials Insulin Syringes (U-100, 1 mL capacity): Per week: 12 syringes (depending on dose